pharmaceutical-investing Invion CEO Maps Path to Peer-level Valuation as Momentum for Cancer Treatment Trials Builds
Jura Announces Dismissal in Full of PEL's Appeal against certain reliefs granted in the Settlement Agreement Arbitral Award